IGMS IGM Biosciences, Inc.: institutional ownership and insider trading
1 funds reported holding $275K of IGM Biosciences, Inc. in their latest 13F filings; in Q4 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of IGMS
- Nuveen Asset Management, LLC — $275K
Recent IGMS insider trades
- Jul 23, 2025: Decker Lisa Lynn sold 4,409 shares ($5.60K)
- Jul 23, 2025: Harler Mary Beth sold 14,501 shares ($18.4K)
- Jul 23, 2025: Tahir Misbah sold 8,741 shares ($11.1K)
- Jun 16, 2025: Decker Lisa Lynn sold 951 shares ($1.14K)
5%+ owners
- T. Rowe Price Associates, Inc.: 10.5% (Schedule 13G/A, filed Feb 14, 2025)